Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States

E-ISSN： 1097-0142|121|15|2544-2552

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.15, 2015-08, pp. : 2544-2552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delivery of neoadjuvant chemoradiation for patients with stage II and III rectal cancer is suboptimal

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 66, Iss. 5, 2016-09 ,pp. : 357-358

John Wiley & Sons Inc

Access to resources Recommend Favorite

Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006‐2014

CANCER, Vol. 124, Iss. 5, 2018-03 ,pp. : 998-1007

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi‐institutional study

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 1937-1948

John Wiley & Sons Inc

Access to resources Recommend Favorite

Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 5, 2015-05 ,pp. : 315-320

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plasma miR-221 as a Predictive Biomarker for Chemoresistance in Breast Cancer Patients who Previously Received Neoadjuvant Chemotherapy

Oncology Research and Treatment, Vol. 34, Iss. 12, 2011-11 ,pp. : 675-680

Karger

Access to resources Recommend Favorite